Home
Alzheimer’s Disease
First Drug Candidate
Pharmakure Solution
The Team
Investors
News
Contact
Menu
Home
Alzheimer’s Disease
First Drug Candidate
Pharmakure Solution
The Team
Investors
News
Contact
Pharmakure's key focus is Alzheimer's Disease, where no effective treatments exist, leading to enormous human and financial cost
Our strategy is to discover new uses for known compounds or drugs through our phenotypic screening methods
This strategy offers great promise for quickly bringing new therapeutic options to Alzheimer's patients
PharmaKure already owns intellectual property on one
drug discovered by our screening approach
This first drug PK051 is ready for Phase 2 clinical trials
IF WE COULD DELAY THE AGE OF ONSET OF ALZHEIMER'S DISEASE BY 5 YEARS
THERE WOULD BE ENORMOUS HUMAN AND FINANCIAL BENEFITS
PharmaKure is a drug development company
a spin out from The University of Manchester